Fisher Asset Management’s ELITE PHARMACEUTICAL ELI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-82,000
| Closed | -$7.69K | – | 1164 |
|
|
2023
Q3 | $7.69K | Buy |
+82,000
| New | +$7.69K | ﹤0.01% | 1103 |
|
|
2023
Q2 | – | Sell |
-82,000
| Closed | -$2.38K | – | 1217 |
|
|
2023
Q1 | $2.38K | Buy |
+82,000
| New | +$2.38K | ﹤0.01% | 1094 |
|
|
2022
Q4 | – | Sell |
-82,000
| Closed | -$3K | – | 1074 |
|
|
2022
Q3 | $3K | Hold |
82,000
| – | – | ﹤0.01% | 931 |
|
|
2022
Q2 | $4K | Hold |
82,000
| – | – | ﹤0.01% | 921 |
|
|
2022
Q1 | $3K | Hold |
82,000
| – | – | ﹤0.01% | 944 |
|
|
2021
Q4 | $3K | Buy |
+82,000
| New | +$3K | ﹤0.01% | 960 |
|